Brimonidine-d4 D-tartrate

• CAT Number: S000401
• CAS Number: 1316758-27-6
• Molecular Formula: C15H12D4BrN5O6
• Molecular Weight: 446.25
• Purity: ≥95%
• IUPAC Name: 5-bromo-N-(4,4,5,5-tetradeuterio-1H-imidazol-2-yl)quinoxalin-6-amine;(2S,3S)-2,3-dihydroxybutanedioic acid
• InChI: InChI=1S/C11H10BrN5.C4H6O6/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8;5-1(3(7)8)2(6)4(9)10/h1-4H,5-6H2,(H2,15,16,17);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.0/s1/i5D2,6D2
• InChIKey: QZHBYNSSDLTCRG-IQSCRJKKSA-N
• SMILES: C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.C(C(C(=O)O)O)(C(=O)O)O

Brimonidine-d4 D-tartrate（Cat No.:S000401） is a deuterated version of brimonidine tartrate, where four hydrogen atoms are replaced with deuterium. This structural enhancement improves the drug’s stability and facilitates more accurate pharmacokinetic and metabolic studies. Brimonidine is an alpha-2 adrenergic receptor agonist used primarily to lower intraocular pressure in patients with glaucoma or ocular hypertension. It reduces aqueous humor production and increases uveoscleral outflow. The D-tartrate salt form improves its solubility and bioavailability.